• I-BET-762: BET Inhibitor Workflows for Ferroptosis & Inflamm

  2026-06-21

  I-BET-762 sets a benchmark for selective BET bromodomain inhibition, enabling robust experimental workflows in cancer and inflammatory disease models. This article translates the latest research—including enhanced ferroptosis induction and transcriptional control—into actionable protocols and troubleshooting strategies for advanced preclinical studies.

• Suhuang Capsule Inhibits ER Stress and NLRP3 Inflammasome in

  2026-06-20

  The referenced study demonstrates that Suhuang antitussive capsule ameliorates pulmonary dysfunction in cough variant asthma by inhibiting endoplasmic reticulum (ER) stress and NLRP3 inflammasome activation. These findings clarify a mechanistic link between ER stress modulation and improved pulmonary outcomes, providing a foundation for future therapeutic exploration.

• Spatially Targeted mTORC1 Inhibition Reveals Nuclear Functio

  2026-06-19

  The reference study introduces TerminaTOR, a genetically encoded tool enabling precise inhibition of mTORC1 at defined subcellular locations. This work uncovers distinct transcriptional roles for nuclear mTORC1, advancing our understanding of spatial compartmentalization in PI3K/Akt/mTOR signaling and its implications for gene regulation.

• Caspofungin: Workflow Innovations for Antifungal Research

  2026-06-19

  Caspofungin stands out as a lipopeptide antifungal drug for translational research on resistant Candida infections, enabling robust, reproducible workflows targeting β-(1,3)-D-glucan biosynthesis. This article demystifies applied protocols, experimental troubleshooting, and key comparative insights, ensuring scientists capitalize on APExBIO's high-purity Caspofungin for advanced antifungal studies.

• Viral Induction of RIPK3 Degradation Regulates Necroptosis a

  2026-06-18

  Liu et al. (2021) identify a novel orthopoxvirus-encoded protein that triggers proteasome-mediated degradation of RIPK3, thereby regulating necroptosis and virus-induced inflammation in host cells. This discovery advances understanding of how viruses manipulate the ubiquitin-proteasome pathway to evade host immune responses, with implications for antiviral and inflammation research.

• Dabigatran Etexilate: Clinical Evidence for Oral Thrombin In

  2026-06-18

  This article reviews the pivotal clinical evidence supporting Dabigatran etexilate as the first oral direct thrombin inhibitor for stroke and VTE prevention. The reference study establishes its pharmacological advantages over traditional anticoagulants, offering predictable efficacy and a simplified workflow for atrial fibrillation research and clinical management.

• Trypsin as a Serine Protease: Workflows for Wound Healing Re

  2026-06-17

  Trypsin, a serine protease, is pivotal for precise protein hydrolysis in advanced wound healing and cell biology workflows. This article bridges bench protocols with translational applications, highlighting troubleshooting strategies and the impact of recent hydrogel innovations.

• UBC9-Mediated SUMOylation of PINK1 Modulates Mitophagy in PD

  2026-06-17

  This study demonstrates that UBC9 regulates mitophagy and alleviates oxidative stress in Parkinson’s disease models via SUMOylation of PINK1. The findings clarify a mechanistic link between UBC9, PINK1 stability, and neuronal survival, suggesting UBC9 as a potential preventive target in PD progression.

• JNK-IN-7: Precision Modulation of JNK Pathways in Apoptosis

  2026-06-16

  Explore how JNK-IN-7, a selective JNK inhibitor, enables targeted investigation of apoptosis and innate immune signaling. This cornerstone guide uniquely bridges mechanistic insight with advanced assay design for MAPK pathway research.

• Nuclear cGAS Restricts L1 Retrotransposition via CHK2-TRIM41

  2026-06-16

  This study uncovers a key nuclear function of cGAS in repressing LINE-1 (L1) retrotransposition by promoting TRIM41-mediated degradation of L1-encoded ORF2p, a process dependent on CHK2-mediated phosphorylation of cGAS. These findings illuminate a previously underappreciated axis linking DNA damage response, genome stability, and retrotransposon control, with implications for aging and cancer biology.

• Bacitracin (B1670): Technical Parameters for Antibacterial R

  2026-06-15

  Bacitracin (B1670) is a peptide antibiotic optimized for laboratory research targeting bacterial cell wall synthesis in both gram-positive and gram-negative bacteria. It is not intended for diagnostic or clinical use, and proper workflow setup is critical for reproducible results.

• MLN2238 and the CRTC-CREB Axis: A New Era in Proteasome Rese

  2026-06-15

  Explore how MLN2238, a potent proteasome β5 subunit inhibitor, uniquely modulates the CRTC-CREB axis and redox responses. This article offers novel insights for oncology and proteostasis research, bridging molecular mechanisms with practical assay innovation.

• Exemestane: Steroidal Aromatase Inhibitor for Breast Cancer

  2026-06-14

  Exemestane, a selective and irreversible steroidal aromatase inhibitor, empowers researchers to dissect estrogen biosynthesis and hormone-driven cancer pathways with high precision. Its robust inhibition profile and compatibility with advanced cell and tissue models make it indispensable for contemporary breast cancer research workflows.

• Cytochalasin B: Precision Inhibitor for Cytoskeletal Researc

  2026-06-13

  Cytochalasin B (NSC 107658) revolutionizes cytoskeletal research by selectively disrupting actin dynamics, enabling high-fidelity interrogation of cell motility pathways and host-pathogen interactions. This guide synthesizes advanced protocols, real-world troubleshooting, and translational insights from landmark studies to help researchers maximize experimental reproducibility.

• T0070907: A Next-Generation Tool for Dissecting PPARγ Pathwa

  2026-06-12

  Explore the advanced mechanistic and translational insights of T0070907, a potent PPARγ antagonist, in modulating PPARγ/RXRα signaling, adipogenesis, and cell cycle regulation. This article uniquely integrates cutting-edge findings on transcriptional repression with practical considerations for experimental design.

463 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page